This study investigated routinely measured serum biomarkers and revealed that CA125 measurement can supplement CA19-9 and increase the diagnostic accuracy of predicting IPMN malignancy. Here, MUC16 is linked to pancreatic intraductal papillary-mucinous neoplasm.